Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:1105-1110

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, S.I.
Right arrow Articles by Pirola, C.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, S.I.
Right arrow Articles by Pirola, C.J.

(Hypertension. 1995;26:1105-1110.)
© 1995 American Heart Association, Inc.


Articles

Thyrotropin-Releasing Hormone Hyperactivity in the Preoptic Area of Spontaneously Hypertensive Rats

S.I. Garcia; S.M. Dabsys; V.N. Martinez; A. Delorenzi; D. Santajuliana; V.E. Nahmod; S. Finkielman; C.J. Pirola

From the Departamento de Sustancias Vasoactivas, Instituto de Investigaciones Medicas "A. Lanari," Facultad de Medicina, Universidad de Buenos Aires (Argentina).

Correspondence to Carlos J. Pirola, PhD, Instituto de Investigaciones Medicas "A. Lanari," Donato Alvarez 3150, Buenos Aires 1427, Argentina.

Abstract Thyrotropin-releasing hormone (TRH) plays an important role in central cardiovascular regulation through the activation of different neurotransmitter systems at distinct extrahypothalamic sites. To study possible alterations in the TRH system in the hypertensive state, we measured TRH concentration in cerebrospinal fluid and TRH content of the preoptic area in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) by radioimmunoassay. In addition, we also measured the density of the TRH receptor in this area by a rapid filtration technique using [3H]methyl-TRH. We found a significant increase in both the TRH content (634±61 versus 350±26 pg/mg protein, SHR versus WKY; P<.01, n=5) and density of TRH receptors without changes in affinity (Bmax, 5.0±0.1 versus 3.3±0.1 fmol/mg protein, P<.01, n=4). An increase in TRH concentration was also found in the cerebrospinal fluid of SHR (30±3 versus 21±2 pg/mL, P<.01, n=5), suggesting increased TRH release in the central nervous system. Northern blot analysis indicated a threefold augmented abundance of TRH precursor mRNA in the preoptic area of SHR. A polyclonal antibody raised against TRH injected peripherally or intracerebroventricularly lowered arterial blood pressure in SHR but not in WKY. In addition, long-term treatment with enalapril (5 mg/kg twice daily), which was effective in inhibiting serum angiotensin-converting enzyme activity by more than 50%, decreased arterial blood pressure and preoptic area TRH content of SHR, whereas another vasodilator, diltiazem (10 mg/kg every 8 hours), failed to produce a similar change. These results point out an activation of the TRH system, with increased production of TRH and an upregulation of its receptors in this genetic model of hypertension.


Key Words: prothyroliberin • rats, inbred SHR • preoptic area




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. S. Landa, S. I. Garcia, M. L. Schuman, A. Burgueno, A. L. Alvarez, F. E. Saravia, C. Gemma, and C. J. Pirola
Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1388 - E1394.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Hypertension, March 1, 2007; 49(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Gumieniak, S. Hurwitz, T. S. Perlstein, U. C. Ngumezi, P. N. Hopkins, X. Jeunemaitre, and G. H. Williams
Aggregation of High-Normal Thyroid-Stimulating Hormone in Hypertensive Families
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5985 - 5990.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. I. Garcia, M. S. Landa, P. I. Porto, A. L. Alvarez, M. Schuman, S. Finkielman, and C. J. Pirola
Thyrotropin-Releasing Hormone Decreases Leptin and Mediates the Leptin-Induced Pressor Effect
Hypertension, February 1, 2002; 39(2): 491 - 495.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. E. De Wardener
The Hypothalamus and Hypertension
Physiol Rev, October 1, 2001; 81(4): 1599 - 1658.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. I. Garcia, P. I. Porto, G. Dieuzeide, M. S. Landa, T. Kirszner, Y. Plotquin, C. Gonzalez, and C. J. Pirola
Thyrotropin-Releasing Hormone Receptor (TRHR) Gene Is Associated With Essential Hypertension
Hypertension, September 1, 2001; 38(3): 683 - 687.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. I. Garcia, A. L. Alvarez, P. I. Porto, V. M. Garfunkel, S. Finkielman, and C. J. Pirola
Antisense Inhibition of Thyrotropin-Releasing Hormone Reduces Arterial Blood Pressure in Spontaneously Hypertensive Rats
Hypertension, February 1, 2001; 37(2): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. A. Nillni and K. A. Sevarino
The Biology of pro-Thyrotropin-Releasing Hormone-Derived Peptides
Endocr. Rev., October 1, 1999; 20(5): 599 - 648.
[Abstract] [Full Text]